Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ)

29.81 -0.05 (-0.17%) At close: 03:04PM CST

Sunflower Pharmaceutical Group Co.,Ltd

Concentrated Area, Yingbin Road
Harbin High-tech Ind. Dev. Zne No. 18, Donghu Road
Harbin 150078
China
86 451 8236 7108
https://www.kuihuayaoye.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 5,776

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Chunhong Wu	Financial Manager	N/A	N/A	1977
Mr. Jingshang Ren	Deputy GM & Non-Independent Director	N/A	N/A	1962
Mr. Guangguang Zhou	Board Secretary	N/A	N/A	1981
Mr. Jin Ming Lin	Deputy General Manager	N/A	N/A	1963
Mr. Xin Ma	Deputy General Manager	N/A	N/A	1966
Mr. Yang Hai	Deputy General Manager	N/A	N/A	1984
Ms. Yi Guan	GM & Non-Independent Director	N/A	N/A	1982
Mr. Liang Chen	Deputy General Manager	N/A	N/A	1986

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children's medicinal products. The company sells its products under the Sunflower and Little Sunflower brands. Sunflower Pharmaceutical Group Co.,Ltd was founded in 2005 and is headquartered in Harbin, China.

Corporate governance

Sunflower Pharmaceutical Group Co.,Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.